Study on improving Lp(a) testing in heart clinics
Part of Heart & circulation clinical trials.
This trial tests ways to help doctors check for high Lp(a), a risk factor for heart disease, in patients who need it. The study looks at whether special strategies increase testing rates in cardiology centers that currently test less than 15% of eligible patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your center must be a cardiology or similar clinic that already can test for Lp(a) and get it paid for.
- Your clinic must currently test for Lp(a) in less than 15 out of every 100 eligible patients.
- Your clinic must see enough eligible patients each year to meet the study's goals.
- Your clinic must be willing to share data and follow the study plan.
- You are a healthcare provider who manages heart disease risk and your center is joining the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.
This trial tests whether simple electronic letters can motivate people with heart disease to better manage their health, especially their cholesterol levels. If you have high Lp(a) — a type of cholesterol linked to heart risk — you may also get a special letter about that.
This study tests an experimental oral medication, SAL0137, to see if it can lower Lp(a) levels, a type of fat in the blood linked to heart disease. It may help people who have high Lp(a) and are at increased risk for heart attacks or strokes.
This study looks at whether a type of fat in your blood, called lipoprotein(a), can help predict how well you do after a planned procedure to open a blocked heart artery. If you join, we will take a blood sample before the procedure and follow your recovery to see how lipoprotein(a) levels relate to outcomes.
This study looks at levels of a type of cholesterol called Lp(a) in people with certain heart and blood vessel diseases. The goal is to understand how common high Lp(a) is in Russian adults with these conditions.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
Hear when a new Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.